Cantitate/Preț
Produs

Advances in Respiratory Cancerogenesis: Advances in Experimental Medicine and Biology, cartea 911

Editat de Mieczyslaw Pokorski
en Limba Engleză Hardback – 3 iun 2016
Lung cancer is the leading cause of mortality worldwide, with a low survival rate. Carcinogenesis generally requires a constellation of entwined steps, involving both innate cellular and environmental factors. This book shares the updated knowledge on the origin and development of cancer through genotypic changes which upset the physiological balance between cell proliferation, differentiation, growth control, and apoptosis. The emphasis is put on the role of microRNA proteins involved in the cellular processes above outlined. Cognitive changes, related to dysregulated cellular mechanisms in cancer cells, as yet unchartered area of research, also are tackled. A better understanding of the molecular and cellular biology of lung cancer is the key source of breakthroughs in the diagnosis and prognosis, and finding more effective therapies that target specific mutations. The book provides a source of current facts and trends in clinical research and practice. It will be of interest to clinicians, researchers, and other medical professionals.
 
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 64746 lei  38-44 zile
  Springer International Publishing – 30 mai 2018 64746 lei  38-44 zile
Hardback (1) 70090 lei  3-5 săpt.
  Springer International Publishing – 3 iun 2016 70090 lei  3-5 săpt.

Din seria Advances in Experimental Medicine and Biology

Preț: 70090 lei

Preț vechi: 73778 lei
-5% Nou

Puncte Express: 1051

Preț estimativ în valută:
13414 13933$ 11142£

Carte disponibilă

Livrare economică 11-25 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319350974
ISBN-10: 3319350978
Pagini: 87
Ilustrații: VIII, 87 p.
Dimensiuni: 178 x 254 x 10 mm
Greutate: 0.41 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Seriile Advances in Experimental Medicine and Biology, Neuroscience and Respiration

Locul publicării:Cham, Switzerland

Cuprins

Chapter 1. The Role of Dysregulated MicroRNA Expression in Lung Cancer.- Chapter 2. Laryngeal Cancer: 12-Year Experience of a Single Center.- Chapter 3. Polymorphisms of Selected DNA Repair Genes and Lung Cancer in Chromium Exposure.- Chapter 4. Associations of CYP1A2 Polymorphisms with the Risk Haplotypes in Lung Cancer in the Slovak Population.- Chapter 5. Diagnostic Yield of Endobronchial Ultrasound Guided Transbronchial Needle Aspiration in Patients with Mediastinal Lymph Node Enlargement. - Chapter 6. The Effect on Cognition of Mitochondrial Respiratory System Proteins in Peripheral Blood Mononuclear Cells in the Course of Lung Cancer.- Chapter 7. Lung Cancer and Multiple Neoplasms: a Retrospective Analysis.- Chapter 8. Humoral Immune Response against Neural Antigens and its Effects on Cognition in Lung Cancer Patients. – Chapter 9. Active Case Finding Among Homeless People as a Means of Reducing the Incidence of Pulmonary Tuberculosis in General Population.- Chapter 10. Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. 

Textul de pe ultima copertă

Lung cancer is the leading cause of mortality worldwide, with a low survival rate. Carcinogenesis generally requires a constellation of entwined steps, involving both innate cellular and environmental factors. This book shares the updated knowledge on the origin and development of cancer through genotypic changes which upset the physiological balance between cell proliferation, differentiation, growth control, and apoptosis. The emphasis is put on the role of microRNA proteins involved in the cellular processes above outlined. Cognitive changes, related to dysregulated cellular mechanisms in cancer cells, as yet unchartered area of research, also are tackled. A better understanding of the molecular and cellular biology of lung cancer is the key source of breakthroughs in the diagnosis and prognosis, and finding more effective therapies that target specific mutations. The book provides a source of current facts and trends in clinical research and practice. It will be of interest to clinicians, researchers, and other medical professionals.
 

Caracteristici

Genotyping-based lung cancer diagnosis The potential to deliver big benefits to patients Keeping up-to-date with current progress in clinical practice and research